The clinical study of anti-BCMA CAR-T with single-domain antibody as antigen binding domain.

8025Background: Relapsed/refractory (RR) multiple myeloma (MM), RRMM, remains as an incurable disease and has a 5-year survival rate of nearly 50%. To address the unmet medical need, an autologous ...